메뉴 건너뛰기




Volumn 233, Issue 1-2, 2005, Pages 61-65

Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis

Author keywords

Controlled trials; Experimental autoimmune encephalomyelitis; Immunoglobulin G; Intravenous immunoglobulin; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G;

EID: 20444408392     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.03.005     Document Type: Conference Paper
Times cited : (40)

References (26)
  • 1
    • 0035818044 scopus 로고    scopus 로고
    • Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
    • M.D. Kazatchkine, and S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 2001 747 755
    • (2001) N Engl J Med , vol.345 , pp. 747-755
    • Kazatchkine, M.D.1    Kaveri, S.V.2
  • 2
    • 0033040882 scopus 로고    scopus 로고
    • Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases
    • M. Stangel, K.V. Toyka, and R. Gold Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases Arch Neurol 56 1999 661 663
    • (1999) Arch Neurol , vol.56 , pp. 661-663
    • Stangel, M.1    Toyka, K.V.2    Gold, R.3
  • 3
    • 0030892121 scopus 로고    scopus 로고
    • Intravenous immune globulin therapy for neurologic diseases
    • M.C. Dalakas Intravenous immune globulin therapy for neurologic diseases Ann Intern Med 126 1997 721 730
    • (1997) Ann Intern Med , vol.126 , pp. 721-730
    • Dalakas, M.C.1
  • 5
    • 0024472593 scopus 로고
    • Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses
    • F. Rossi, G. Dietrich, and M. Kazatchkine Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses Immunol Rev 110 1989 135 149
    • (1989) Immunol Rev , vol.110 , pp. 135-149
    • Rossi, F.1    Dietrich, G.2    Kazatchkine, M.3
  • 6
    • 0028090333 scopus 로고
    • Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin
    • D. Amran, H. Renz, G. Lack, K. Bradley, and E.W. Gelfand Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin Clin Immunol Immunopathol 73 1994 180 186
    • (1994) Clin Immunol Immunopathol , vol.73 , pp. 180-186
    • Amran, D.1    Renz, H.2    Lack, G.3    Bradley, K.4    Gelfand, E.W.5
  • 7
    • 0035283346 scopus 로고    scopus 로고
    • Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis
    • O. Aktas, S. Waiczies, U. Grieger, U. Wendling, R. Zschenderlein, and F. Zipp Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis J Neuroimmunol 114 2001 160 167
    • (2001) J Neuroimmunol , vol.114 , pp. 160-167
    • Aktas, O.1    Waiczies, S.2    Grieger, U.3    Wendling, U.4    Zschenderlein, R.5    Zipp, F.6
  • 8
    • 0029560231 scopus 로고
    • Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant
    • J.C. Lorentzen, S. Issazadeh, M. Storch, M.I. Mustafa, H. Lassmann, and C. Linington Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant J Neuroimmunol 63 1995 193 205
    • (1995) J Neuroimmunol , vol.63 , pp. 193-205
    • Lorentzen, J.C.1    Issazadeh, S.2    Storch, M.3    Mustafa, M.I.4    Lassmann, H.5    Linington, C.6
  • 9
    • 0034256068 scopus 로고    scopus 로고
    • Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats
    • N. Tanuma, T. Shin, and Y. Matsumoto Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats J Neuroimmunol 108 2000 171 180
    • (2000) J Neuroimmunol , vol.108 , pp. 171-180
    • Tanuma, N.1    Shin, T.2    Matsumoto, Y.3
  • 10
    • 24144487121 scopus 로고    scopus 로고
    • Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically
    • S. Humle Jorgensen, P.E.H. Jensen, H. Laursen, and P.S. Sorensen Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically Neurol Res 2005 (in press)
    • (2005) Neurol Res
    • Humle Jorgensen, S.1    Jensen, P.E.H.2    Laursen, H.3    Sorensen, P.S.4
  • 12
    • 0025099773 scopus 로고
    • Immunoglobulins promote remyelination in the central nervous system
    • M. Rodriguez, and VA. Lennon Immunoglobulins promote remyelination in the central nervous system Ann Neurol 27 1990 12 17
    • (1990) Ann Neurol , vol.27 , pp. 12-17
    • Rodriguez, M.1    Lennon, V.A.2
  • 13
    • 0034612279 scopus 로고    scopus 로고
    • Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
    • A.E. Warrington, K. Asakura, A.J. Bieber, B. Ciric, V. Keulen, and S.V. Kaveri Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis Proc Natl Acad Sci U S A 97 2000 6820 6825
    • (2000) Proc Natl Acad Sci U S a , vol.97 , pp. 6820-6825
    • Warrington, A.E.1    Asakura, K.2    Bieber, A.J.3    Ciric, B.4    Keulen, V.5    Kaveri, S.V.6
  • 14
    • 0031057970 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group
    • F. Fazekas, F. Deisenhammer, S. Strasser Fuchs, G. Nahler, and B. Mamoli Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group Lancet 349 1997 589 593
    • (1997) Lancet , vol.349 , pp. 589-593
    • Fazekas, F.1    Deisenhammer, F.2    Strasser Fuchs, S.3    Nahler, G.4    Mamoli, B.5
  • 15
    • 0031911494 scopus 로고    scopus 로고
    • Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
    • A. Achiron, U. Gabbay, R. Gilad, B.S. Hassin, Y. Barak, and M. Gornish Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses Neurology 50 1998 398 402
    • (1998) Neurology , vol.50 , pp. 398-402
    • Achiron, A.1    Gabbay, U.2    Gilad, R.3    Hassin, B.S.4    Barak, Y.5    Gornish, M.6
  • 17
    • 0036833722 scopus 로고    scopus 로고
    • Low dose of intravenous immunoglobulins is equally effective in multiple sclerosis as high dose. Clinical and MRI assessment
    • M. Lewanska, M.S. Zajdel, and K. Selmaj Low dose of intravenous immunoglobulins is equally effective in multiple sclerosis as high dose. Clinical and MRI assessment Eur J Neurol 9 2002 565 572
    • (2002) Eur J Neurol , vol.9 , pp. 565-572
    • Lewanska, M.1    Zajdel, M.S.2    Selmaj, K.3
  • 18
    • 0036835646 scopus 로고    scopus 로고
    • Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: A meta-analysis
    • P.S. Sorensen, F. Fazekas, and M. Lee Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis Eur J Neurol 9 2002 557 563
    • (2002) Eur J Neurol , vol.9 , pp. 557-563
    • Sorensen, P.S.1    Fazekas, F.2    Lee, M.3
  • 19
    • 0037441359 scopus 로고    scopus 로고
    • The role of intravenous immunoglobulin in the treatment of multiple sclerosis
    • P.S. Sorensen The role of intravenous immunoglobulin in the treatment of multiple sclerosis J Neurol Sci 206 2003 123 130
    • (2003) J Neurol Sci , vol.206 , pp. 123-130
    • Sorensen, P.S.1
  • 20
    • 4644250609 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in secondary progressive multiple sclerosis: Randomised placebo-controlled trial
    • O.R. Hommes, P.S. Sorensen, F. Fazekas, M.M. Enriquez, H.W. Koelmel, and O. Fernandez Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial Lancet 364 2004 1149 1156
    • (2004) Lancet , vol.364 , pp. 1149-1156
    • Hommes, O.R.1    Sorensen, P.S.2    Fazekas, F.3    Enriquez, M.M.4    Koelmel, H.W.5    Fernandez, O.6
  • 22
    • 0033763213 scopus 로고    scopus 로고
    • High dose IVIG in the post partum period for prevention of exacerbations in MS
    • J. Haas High dose IVIG in the post partum period for prevention of exacerbations in MS Mult Scler 6 suppl. 2 2000 18 20
    • (2000) Mult Scler , vol.6 , Issue.2 SUPPL. , pp. 18-20
    • Haas, J.1
  • 23
    • 0035849518 scopus 로고    scopus 로고
    • A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis
    • J.H. Noseworthy, P.C. O'Brien, T.M. Petterson, J. Weis, L. Stevens, and W.K. Peterson A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis Neurology 56 2001 1514 1522
    • (2001) Neurology , vol.56 , pp. 1514-1522
    • Noseworthy, J.H.1    O'Brien, P.C.2    Petterson, T.M.3    Weis, J.4    Stevens, L.5    Peterson, W.K.6
  • 25
    • 0034104407 scopus 로고    scopus 로고
    • Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
    • M. Stangel, F. Boegner, C.H. Klatt, C. Hofmeister, and S. Seyfert Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis J Neurol Neurosurg Psychiatry 68 2000 89 92
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 89-92
    • Stangel, M.1    Boegner, F.2    Klatt, C.H.3    Hofmeister, C.4    Seyfert, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.